Cat.#: ACPP-1280
| Despition | SRPX2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1367 | Myocilin Blocking Peptide (AC1367) | 250 µg | inquiry |
| ACPP-1022 | Recombinant Human Integrin beta 1 Protein (Fc Tag) (AC1022) | 50 µg | inquiry |
| ACPP-1607 | Mouse Leptin Protein, PEG (AC1607) | 20 µg | inquiry |
| ACPP-1807 | Human QKI Protein (AC1807) | 2 µg | inquiry |
| ACPP-1258 | Pannexin 1 Blocking Peptide (AC1258) | 250 µg | inquiry |
| ACPP-1268 | Human LGALS3 Protein (AC1268) | 10 µg | inquiry |
| ACPP-1117 | Human BDNF Protein (AC1117) | 2 µg | inquiry |
| ACPP-1481 | Human RDH12 Protein (AC1481) | 2 µg | inquiry |
| ACPP-1260 | iNOS Blocking Peptide (AC1260) | 250 µg | inquiry |
| ACPP-1227 | Pax2 Blocking Peptide (AC1227) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.